Literature DB >> 23261775

The inflammasome: pathways linking psychological stress, depression, and systemic illnesses.

Masaaki Iwata1, Kristie T Ota, Ronald S Duman.   

Abstract

Stress is a common occurrence in everyday life and repeated or traumatic stress can be a precipitating factor for illnesses of the central nervous system, as well as peripheral organ systems. For example, severe or long-term psychological stress can not only induce depression, a leading illness worldwide, but can also cause psychosomatic diseases such as asthma and rheumatoid arthritis. Related key questions include how psychological stress influences both brain and peripheral systems, and what detection mechanisms underlie these effects? A clue is provided by the discovery of the pathways underlying the responses to host "danger" substances that cause systemic diseases, but can also contribute to depression. The inflammasome is a protein complex that can detect diverse danger signals and produce the accompanying immune-inflammatory reactions. Interestingly, the inflammasome can detect not only pathogen-associated molecules, but also cell damage-associated molecules such as ATP. Here, we propose a new inflammasome hypothesis of depression and related comorbid systemic illnesses. According to this hypothesis, the inflammasome is a central mediator by which psychological and physical stressors can contribute to the development of depression, and as well as a bridge to systemic diseases. This hypothesis includes an explanation for how psychological stress can influence systemic diseases, and conversely how systemic diseases can lead to psychiatric illnesses. The evidence suggests that the inflammasome may be a new target for the development of treatments for depression, as well as psychosomatic and somato-psycho diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23261775      PMCID: PMC4426992          DOI: 10.1016/j.bbi.2012.12.008

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  135 in total

1.  Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons.

Authors:  C S Woolley; E Gould; B S McEwen
Journal:  Brain Res       Date:  1990-10-29       Impact factor: 3.252

2.  Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain.

Authors:  V H Perry; D A Hume; S Gordon
Journal:  Neuroscience       Date:  1985-06       Impact factor: 3.590

3.  Major depressive disorder and disease activity in systemic lupus erythematosus.

Authors:  Fabiano G Nery; Eduardo F Borba; John P Hatch; Jair C Soares; Eloísa Bonfá; Francisco Lotufo Neto
Journal:  Compr Psychiatry       Date:  2006-05-24       Impact factor: 3.735

4.  P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.

Authors:  Susanne Lucae; Daria Salyakina; Nicholas Barden; Mario Harvey; Bernard Gagné; Michel Labbé; Elisabeth B Binder; Manfred Uhr; Marcelo Paez-Pereda; Inge Sillaber; Marcus Ising; Tanja Brückl; Roselind Lieb; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Hum Mol Genet       Date:  2006-07-05       Impact factor: 6.150

5.  HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients.

Authors:  Alessandra Pontillo; Lais T Silva; Telma M Oshiro; Claudia Finazzo; Sergio Crovella; Alberto J S Duarte
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

6.  Impact of depressive symptoms on adult asthma outcomes.

Authors:  Mark D Eisner; Patricia P Katz; Gretchen Lactao; Carlos Iribarren
Journal:  Ann Allergy Asthma Immunol       Date:  2005-05       Impact factor: 6.347

7.  Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally.

Authors:  R M Bluthé; B Michaud; K W Kelley; R Dantzer
Journal:  Neuroreport       Date:  1996-06-17       Impact factor: 1.837

8.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

9.  The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Authors:  N Müller; M J Schwarz; S Dehning; A Douhe; A Cerovecki; B Goldstein-Müller; I Spellmann; G Hetzel; K Maino; N Kleindienst; H-J Möller; V Arolt; M Riedel
Journal:  Mol Psychiatry       Date:  2006-02-21       Impact factor: 15.992

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

View more
  165 in total

Review 1.  P2X ion channel receptors and inflammation.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2016-01-06       Impact factor: 3.765

Review 2.  The Immune System and the Role of Inflammation in Perinatal Depression.

Authors:  Philippe Leff-Gelman; Ismael Mancilla-Herrera; Mónica Flores-Ramos; Carlos Cruz-Fuentes; Juan Pablo Reyes-Grajeda; María Del Pilar García-Cuétara; Marielle Danitza Bugnot-Pérez; David Ellioth Pulido-Ascencio
Journal:  Neurosci Bull       Date:  2016-07-18       Impact factor: 5.203

3.  Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.

Authors:  Alan M Rathbun; Leslie R Harrold; George W Reed
Journal:  Clin Rheumatol       Date:  2014-08-27       Impact factor: 2.980

4.  Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.

Authors:  Anindya Bhattacharya; Qi Wang; Hong Ao; James R Shoblock; Brian Lord; Leah Aluisio; Ian Fraser; Diane Nepomuceno; Robert A Neff; Natalie Welty; Timothy W Lovenberg; Pascal Bonaventure; Alan D Wickenden; Michael A Letavic
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

5.  Neurobiological advances identify novel antidepressant targets.

Authors:  Ronald S Duman
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 6.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 7.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

8.  Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain.

Authors:  Eric S Wohleb; Daniel B McKim; Daniel T Shea; Nicole D Powell; Andrew J Tarr; John F Sheridan; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-12-10       Impact factor: 13.382

Review 9.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

10.  High-Fat Diet Induced Anxiety and Anhedonia: Impact on Brain Homeostasis and Inflammation.

Authors:  Sophie Dutheil; Kristie T Ota; Eric S Wohleb; Kurt Rasmussen; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2015-12-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.